| Authors: |
Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, Centre Oscar Lambret, University of Paris Saclay, Villejuif, France. Electronic address: k-fizazi@o-lambret.fr., Clarke NW; The Christie and Salford Royal NHS Foundation Trusts, University of Manchester, Manchester, UK., De Santis M; Charite Universitätsmedizin Berlin, Berlin, Germany; Medical University of Vienna, Vienna, Austria., Uemura H; Kindai University Hospital, Osaka, Japan., Fay AP; Hospital Nora Teixeira and PUCRS School of Medicine, Porto Alegre, Brazil., Karadurmus N; SBU Gulhane Training and Research Hospital, Ankara, Turkey., Kwiatkowski M; Szpital Wojewódzki w Koszalinie, Koszalin, Poland., Alvarez-Fernandez C; Hospital Universitario Central de Asturias, Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain., Jiang S; Hunan Cancer Hospital, Hunan, China., Sotelo M; Hospital Maria Auxiliadora, Lima, Peru., Parslow D; Derriford Hospital, Plymouth, UK., Oliveira N; Mater Hospital Brisbane, Mater Misericordiae Ltd, Brisbane, Australia; Mater Clinical Unit, School of Clinical Medicine, The University of Queensland, Brisbane, Australia., Kwon TG; Kyungpook National University Chilgok Hospital, Daegu, South Korea., Ye D; Fudan University Shanghai Cancer Center, Shanghai, China., Boudewijns S; Bravis Ziekenhuis, Roosendaal, The Netherlands., Danchaivijitr P; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand., Rooney C; AstraZeneca, Cambridge, UK., Gresty C; AstraZeneca, Cambridge, UK., Yeste-Velasco M; AstraZeneca, Barcelona, Spain., Logan J; AstraZeneca, Gaithersburg, USA., George DJ; Duke University Cancer Institute, Durham, USA. |
